In the treatment of inflammatory bowel disease, synthetic mucus gels can be used to deliver monoclonal antibodies without inducing broad immunosuppression.
Pancreatic cancer uses a sugar-coated disguise to evade the immune system, helping explain why it’s so hard to treat.
Mindwalk identified TDP-43 antibodies that selectively target abnormal protein clumps linked to ALS and other diseases.
Monoclonal antibodies (mAbs) aid the body against autoimmune diseases and cancer, among other things. Patients have to pick ...
As Lindsey Vonn’s comeback run heads toward a peak with Team USA at the upcoming 2026 Winter Olympics, Invivyd is adding the ...
Bio‑Sourcing and Zerion Pharma A/S today announce that their joint project to develop an oral formulation of Trastuzumab, the pioneer monoclonal antibody used to treat breast cancer, has been awarded ...
Bio-Sourcing and Zerion Pharma have obtained a €1.3 million EU grant reward under the Eurostars program to advance an orally administered anti-HER2, antibody Trastuzimab, for treatment of breast cance ...
A new computer model could help predict and improve antibody drug formulations. The goal is for patients to be able to ...
Researchers have identified a promising new weapon against triple-negative breast cancer, one of the most aggressive forms of ...
Kiniksa (KNSA) shifts from survival to growth as Arcalyst nears blockbuster sales and pipeline KPL-387 readouts loom—get the ...
A team from Würzburg has fundamentally changed our understanding of platelet biology. The researchers demonstrate that the ...
Phase 2 clinical trial will evaluate the safety, translational biology, and exploratory clinical efficacy of VYD2311 in people with Long COVID or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results